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Background and purpose: Neuropathological studies have demonstrated that multiple system atrophy (MSA) 
produces selective atrophy of the putamen with sparing of the caudate nucleus, while both structures are spared 
in idiopathic Parkinson’s disease (PD). In this study we evaluated the clinical efficacy of using putaminal atrophy in 
brain MRI to differentiate MSA and PD.
Methods: We measured the putamen/caudate volume ratio on brain MRI in 24 patients with MSA and 21 patients 
with PD. Two clinicians who were blinded to the patients’ diagnoses and to each other’s assessments measured 
the volume ratio using a computer program.
Results: The measured volume ratios of the two investigators were highly correlated (r=0.72, p<0.0001). The 
volume ratio was significantly lower in MSA (1.29±0.28) than PD (1.91±0.29, p<0.0001). Setting an arbitrary cutoff 
ratio of 1.6 resulted in about 90% of patients with MSA falling into the group with a lower ratio, whereas more than 
80% of patients with PD belonged to the other group.
Conclusions: The present results demonstrate that putaminal atrophy in MSA as measured on brain MRI 
represents an effective tool for differentiating MSA from PD.
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INTRODUCTION
Clinical differentiation between idiopathic Parkinson’s 
disease (PD) and the striatonigral variant of multiple 
system atrophy (MSA-P) is often difficult, particularly at 
the early stages. The main pathologic change observed 
in MSA-P is striatal degeneration in addition to the 
nigral cell loss seen in PD.1 Recent magnetic resonance 
imaging (MRI)-based volumetry studies have shown that 
the striatal volume is lower in MSA-P than in PD.2,3 
However, the requirement to set a specific volume cutoff 
threshold is problematic due to the wide overlap 
between the two diseases (presumably resulting from the 
individual variation in absolute striatal size), which 
limits the diagnostic usefulness of MRI volumetry in 
routine clinical practice.2 Interestingly, the pattern of 
striatal degeneration in MSA-P is characterized by 
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Figure 1. Axial T2-weighted magnetic resonance imaging 
showing the outlines of the putamen and caudate nucleus. 
The volume of each structure was calculated as the sum of 
the area measured on each section that contained it.
Figure 2. Scatter diagram showing the putamen/caudate 
volume ratio as measured by two investigators in patients 
with Parkinson’s disease (PD; filled circles) and in those 
with the striatonigral variant of multiple system atrophy 
(MSA-P; open circles). This ratio was significantly higher in 
patients with PD than in those with MSA-P (according to 
the measurements of both investigators). An arbitrary cutoff 
of 1.6 differentiated more than 80% of the patients with 
these two diseases.
predominant involvement of the putamen with relative 
sparing of the caudate nucleus;1 this may result in a 
reduced the putamen/caudate volume ratio (PC ratio), 
which may be beneficial in reducing interindividual 
variability. Thus, we measured the PC ratio on routine 
brain MRI images to test its clinical value in early 
differentiation between MSA-P and PD.
MATERIALS AND METHODS
The study subjects comprised 24 consecutive patients 
with MSA-P (12 men and 12 women; age 65.5±7.1 
years, mean±SD) and 21 consecutive patients with PD 
(4 men and 17 women; age 65.2±10.3 years), all of 
whom underwent brain MRI and had symptoms for 3 
years or less. Clinical diagnoses of PD and MSA-P were 
based on the UK brain bank criteria4 and MSA con-
sensus criteria,5 respectively. 
T2-weighted brain MRI (TR=4000 ms, TE=98 ms) was 
undertaken using a 1.5-T device (Signa Horizon Echo 
Speed, GE, Milwaukee, WI) with a standard quadrature 
head coil and a transaxial image slice thickness of 7 mm. 
Two neurologists (Drs. Kang and Yang) who were 
blinded to each other’s assessments and the patients’ 
diagnoses delineated the putamen and the caudate 
nucleus using a computer pen-based mouse on all the 
T2-weighted axial MRI images containing these struc-
tures using Scion Image® (Fig. 1). The volumes of these 
structures were calculated by multiplying the measured 
area by the number of slices containing them (i. e., 
measured area  number of slices containing the structure 
7 mm). For each patient, the mean ratio of both sides 
was used in the analyses.
Simple regression analysis was used to evaluate the 
relationship between the measurements of the two 
investigators, and to test the relationship between PC 
ratio and symptom duration or symptom severity. The 
unpaired t-test was employed to compare values between 
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MSA-P and PD patients, with probability values of 
p<0.05 considered statistically significant.
RESULTS
Age and symptom duration were comparable between 
the two groups: the age was 65.3±10.3 and 65.5±7.1 
years, and the symptom duration was 20.0±14.0 and 
15.9±10.4 months in PD and MSA-P, respectively. 
However, symptom severity based on Hoehn & Yahr 
stage was significantly higher in patients with MSA-P 
due to early development of postural instability (1.8±0.64 
in PD and 2.71±0.57 in MSA-P).
The measured PC ratios of the two investigators were 
highly correlated (r=0.72, p<0.0001), although a certain 
amount of discordance was evident for individual 
patients (Fig. 2). The mean PC ratios of both investi-
gators were significantly lower (p<0.0001) in MSA-P 
(1.29±0.24) than in PD (1.91±0.29). Setting an arbitrary 
cutoff ratio of 1.6 resulted in 91.7% and 87.5% patients 
with MSA (according to investigators 1 and 2, res-
pectively) falling into the group with a lower ratio, 
while 81.0% and 85.7% of patients with PD (according 
to investigators 1 and 2, respectively) were in the other 
group (Fig. 2). PC ratios in the MSA-P group were not 
correlated with either symptom duration (r=0.13 and 
p=0.55) or symptom severity (i.e., Hoehn & Yahr stage) 
(r=0.25 and p=0.24).
DISCUSSION
This study used routine MRI with a 7-mm slice thick-
ness, and area measurements were performed manually. 
Thus, our absolute volume measurements may be less 
accurate than those in previous MRI volumetry studies 
that employed thinner slices.2,3 However, since the same 
method was applied to measure both structures, we 
assume that the volume ratio itself is more reliable than 
measuring absolute volumes. The high correlation 
between the measurements of the two investigators 
supports this assumption.
MRI volumetry studies have shown that both areas 
are degenerated in MSA-P,2,3 but the reduced PC ratio 
confirmed previous pathological findings that the degree 
of degeneration is much more severe in the putamen 
than in the caudate nucleus.1 Since the striatum is not 
affected in PD,2,3 the PC ratio is presumably similar in 
PD patients and healthy subjects. The relative ease of 
performing routine MRI-based PC ratio measurements in 
clinical practice may represent an advantage over MRI 
volumetry2,3 and other MRI-based methods aimed at 
discriminating between MSA-P and PD.6,7 An arbitrary 
cutoff of 1.6 differentiated more than 80% of the 
patients included in this study. Considering the inter-
investigator variability, this value may not be applicable 
in other experimental settings, but it appears to provide 
useful information for early differentiation of MSA-P 
and PD. 
REFERENCES
 1. Wenning GK, Ben-Shlomo Y, Magalhaes M, Daniel SE, 
Quinn NP. Clinicopathological study of 35 cases of multiple 
system atrophy. J Neurol Neurosurg Psychiatry 1995;58:160- 
166.
 2. Schulz JB, Skalej M, Wedekind D, Luft AR, Abele M, 
Voigt K, et al. Magnetic resonance imaging-based volumetry 
differentiates idiopathic Parkinson’s syndrome from multiple 
system atrophy and progressive supranuclear palsy. Ann 
Neurol 1999;45:65-74.
 3. Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. 
Differentiating multiple system atrophy from Parkinson’s 
disease: contribution of striatal and midbrain MRI volu-
metry and multi-tracer PET imaging. J Neurol Neurosurg 
Psychiatry 2002;73:517-523.
 4. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of 
clinical diagnosis of idiopathic Parkinson’s disease: a clinico- 
pathological study of 100 cases. J Neurol Neurosurg 
Psychiatry 1992;55:181-184.
 5. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo 
Y, Fowler CJ, et al. Consensus statement on the diagnosis 
of multiple system atrophy. J Neurol Sci 1999;163:94-98.
 6. Schocke MF, Seppi K, Esterhammer R, Kremser C, 
Jaschke W, Poewe W, et al. Diffusion-weighted MRI 
differentiates the Parkinson variant of multiple system 
atrophy from PD. Neurology 2002;58:575-580.
 7. Schocke MF, Seppi K, Esterhammer R, Kremser C, Mair 
KJ, Czermak BV, et al. Trace of diffusion tensor diffe-
rentiates the Parkinson variant of multiple system atrophy 
and Parkinson’s disease. Neuroimage 2004;21:1443-1451.
